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Abstract 
Purpose: To evaluate the anticancer activity of linalool against human prostate cancer (DU145) cells. 
Methods: The anticancer activity of linalool against DU145 cancer cells was evaluated by 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Flow cytometry, using propidium 
iodide and Annexin V-FITC, was applied to study apoptosis and cell cycle phase distribution. Inverted 
light microscopy was used to study the effect of linalool on cell morphology and apoptotic body 
formation in DU145 cells while gel electrophoresis was employed to evaluate the effect of linalool on 
DNA fragmentation.  
Results: Linalool induced a dose-dependent as well as time-dependent growth inhibitory effect on 
DU145 prostate cancer cells. It induced sub-G1 phase growth arrest which led to increase in sub-G0/G1 
cell population after treatment with increasing doses of linalool. DNA ladder appeared to be more 
evident with increasing linalool concentration. However, no DNA fragments were observed in the control 
groups. It was observed that 4.36, 11.54, 21.88 and 15.54 % of the cells underwent early apoptosis 
after treatment with 0 (no linalool treatment), 20, 40, and 80 µM of linalool, respectively. Compared to 
control cells, linalool treatment resulted in the appearance of cell shrinkage along with membrane 
blebbing which are characteristic features of cell apoptosis.  
Conclusion: The findings of this study indicate that linalool can be developed as a plant-based 
chemotherapeutic agent against prostate cancer  
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Prostate cancer (PC) is the principal cause of 
new cancer cases and the second most common 
cause of cancer-related deaths in men in United 
States of America [1]. Prevalence rate for clinical 
prostate cancer in Western men are 35 - 45 
times higher than those for Asian men. In the 
United States, prostate cancer accounts for 
about 30 % of all cancer cases in men whereas 
in China, prostate cancer accounts for less than 
2 % of all cancers in men. The survival rate for 
advanced prostate cancer has not improved 
much during the past 10 years [2,3].  
 
The standard treatment options for prostate 
cancer include surgery, radiotherapy and 
hormonal therapy, but these treatment options 
are not without serious side-effects like urinary 
incontinence and sexual dysfunction among 
others. Traditionally, chemotherapy and 
radiotherapy have not provided important 
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survival benefits to patients with advanced 
prostate cancer and most treatment options 
available are only palliative. Recent studies on 
taxane derivatives alone and in combination with 
other chemotherapeutic agents have revealed 
some limited benefit [4], but the need for more 
effective and less toxic means to target and/or 
thwart this disease still exists. Complementary 
and alternative medicine may provide better 
treatment options by inhibiting or slowing down 
disease progression. According to a recent 
survey, around 30 – 40 % of patients suffering 
from prostate cancer use complementary and 
alternative medicine as an additional therapy [5-
7]. 
 
Keeping in view the limited treatment options 
available for prostate cancer along with the side-
effects of known treatment strategies, the aim of 
this study was to identify a plant-based drug 
molecule (linalool, a monoterpene) that will 




Chemicals and biological reagents 
 
Linalool was purchased from Sigma Chemical 
Company (St Louis, MO, USA). The cells were 
cultured in Dulbecco’s modified Eagle’s media 
supplemented with 10 % fetal bovine serum 
(Lonza Biologics, Singapore) and 100 U/mL 
penicillin and 100 μg/mL streptomycin (Vega 
Pharma Limited, Zhejiang, China). MTT kit was 
obtained from Roche (USA). Annexin V-FITC-
Propidium Iodide Apoptosis Detection Kit was 
purchased from Bestbio, Shanghai, China. All 
other chemicals and solvents used were of the 
highest purity grade. Cell culture plastic ware 
was bought from BD Falcon (USA). 
  
Cell line and cell viability assay 
 
Human prostate carcinoma (DU145) cells were 
procured at the China Center for Type Culture 
Collection (Wuhan, China) and grown in a 
humidified 5 % CO2 atmosphere at 37 oC in an 
incubator, and cultured in RPMI-1640 medium 
supplemented with 10 % heat-inactivated 
newborn calf serum, 100 IU/mL penicillin and 
100 μg/mL streptomycin. MTT assay (3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide) was used to measure the inhibition of 
cell proliferation. MTT was added in cells 
exposed to different concentrations (5, 10, 20, 40 
and 80 µM) of linalool for 24 and 48 h. Three 
hours later, the formazan precipitate was 
dissolved in 100 μL dimethyl sulfoxide, and then 
the absorbance was measured in a microplate 
reader (Bio-Rad).The cell viability was calculated 
as in Eq 1. 
 
Inhibition (%) = {(Ac – At)/Ac}100 ………….. (1) 
 
where Ac and At are the absorbance of control 
and treated cells, respectively. 
 
Cell cycle phase distribution analysis  
 
Human prostate carcinoma (DU145) cells (1 × 
105) were seeded in 60-mm dishes and 
subjected to various concentrations (0, 20, 40 
and 80 μM) of linalool for 48 h. The cells were 
collected by trypsinization and washed twice with 
PBS (Sigma Chemical Co.). Cells were 
incubated in 50 % ethanol at -20 oC overnight 
and treated with 40 µg/mL RNase A (Guangzhou 
Geneshun Biotech Ltd. China), and stained with 
10 µg/mL of propidium iodide (PI) (Guangzhou 
Geneshun Biotech Ltd. China). Finally, the 
stained cells were analyzed by FACSCalibur flow 
cytometer (Becton Dickinson, San Jose, CA, 
USA). 
 
DNA fragmentation analysis  
 
After subjecting DU145 cells to linalool treatment 
at various concentrations (0, 20, 40 and 80 µM), 
both adherent and floating cells were collected 
and washed with PBS. Pellets were then lysed 
with DNA lysis buffer (20 mM EDTA, 100 mM 
Tris, pH 8.0, 0.8 % SDS) at room temperature for 
25 min. After centrifugation for 10 min at 12 000 
× g, the supernatants were collected and treated 
with RNase A (final concentration, 500 μg/mL) 
for 20 min at 37 oC, followed by digestion with 
proteinase K (final concentration 500 μg/ml) for 
3.0 h at 55 oC. The DNA was extracted using the 
phenol/chloroform/isoamylol (25:24:1), 
precipitated with ethanol, dissolved in TE buffer 
(10 mM Tris, pH 8.0, 1 mM EDTA), and 
subjected to 2 % agarose gel electrophoresis for 
DNA fragmentation analysis. 
 
Annexin V-FITC assay for cell apoptosis  
 
Apoptosis detection was performed using the 
Annexin V-FITC and PI apoptosis kit (Bestbio, 
Shanghai, China). DU145 cells were plated at a 
density of 2 × 105 cells/well into 12-well plates 
and incubated overnight. Apoptosis was induced 
by treating cells with linalool at various 
concentrations (0, 20, 40 and 80 µM). Cells 
grown in media containing an equivalent amount 
of DMSO without any drug served as control. 
After 48 h of incubation, the cells with different 
treatments were harvested and the final samples 
measured on a FACS Calibur flow cytometry 
(Becton Dickinson, San Jose, CA, USA). 
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DU145 cells were seeded in 6-well plates at 1.5 
× 105 cells per well in 3 mL of complete growth 
medium, incubated for 24 h and treated with 
linalool at various concentrations (0, 20, 40 and 
80 μM). Control cells treated with 0.3 % DMSO 
alone were also included. The morphological 
changes, characteristic of apoptosis or necrosis, 
were observed and the images were captured 
under an inverted light microscope (Olympus, 
PA, USA) after 48 h. The same spot of cells was 




The experiments were performed in triplicate. 
Data were expressed as the mean ± standard 
deviation (SD). Statistical correlation of data was 
checked for significance by ANOVA and 
Student's t test. P < 0.05 was taken to indicate 




Linalool induced strong cytotoxicity in 
human prostate cancer (DU145) cells 
 
The cancer cells showed considerable and dose-
dependent susceptibility to the treatment of 
different concentrations of linalool. The 
compound also showed time-dependent 
inhibition of the cancer cell growth as shown in 
Figure 1 at 24 h and 48 h time intervals. The 
number of viable human prostate cancer cells 
exposed to linalool treatment reduced 
considerably. The IC50 value of the compound 
after 12 h and 24 h time intervals was found to 
be 28.3 and 10.5 µM respectively. 
 
Linalool induces sub-G1 cell cycle arrest and 
increases fraction of apoptotic cells in DU145 
cells  
 
Linalool induced sub-G1 cell cycle arrest with a 
significant increase of apoptotic cells. The results 
showed that treatment with different 
concentrations of linalool for 48 h led to an 
increase in the population of cells in the sub-
G0/G1 phase (apoptotic population) (p < 0.01) 
(Figure 2, A-D). This increase in sub-G1 
population was accompanied by a corresponding 
decrease of the cells in s-phase and G2/M phase 
of the cell cycle. As compared to the control 
(Fig2-A), linalool treated (Fig 2, B, C, D) cells 





Figure 1: Cancer cell growth inhibition by linalool at various concentrations and at two different time intervals 
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Figure 2: Effect of linalool on the cell cycle arrest in human prostate cancer (DU145) cells. Cells (DU145) were 
treated with (B) 20 μM emodin, (C) 40 μM and (D) 80 μM of linalool for 48 h. (A) shows the control (untreated) 
group. The treatment affected the cell cycle distribution and induced apoptosis. The percentage of cells in the 
sub-G1 phase increased significantly with increase in the linalool dose from 0 Μm (A) to 20 (B), 40 (C) and finally 
to 80 Μm (D). The DNA histogram shows the distribution and the percentage of cells in phases of the cell cycle. 
Results are the mean ± SD of 3 independent experiments. Each DNA histogram represents one of the three 
independent experiments 
 
Effect of linalool on DNA fragmentation 
inDU145 human prostate cancer cells 
 
As shown in Figure 3, DNA ladder appeared to 
be more evident with the increasing linalool 
concentration. However, no DNA fragments were 
observed in the control groups (Figure 3, left 
panel). Even lower doses of linalool (5 µM) also 
did not induce DNA fragmentation. However, 40 
and 80 µM doses of linalool resulted in a 
substantial increase in DNA fragmentation 




Figure 3: Linalool induces DNA fragmentation in human prostate cancer cells (DU145). Prostate cancer cells 
were treated with 0, 5, 10, 20, 40 and 80 μM linalool for 48 h. Cells from each sample were harvested for DNA 
gel electrophoresis as described in Materials and methods. Each point is the mean ± SD of three experiments 
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Effect of linalool on DU145 cell apoptosis  
 
The results of Annexin V assay are shown in 
Figure 4A-D. The results of the flow cytometry 
study with Annexin V/FITC and PI showed that 
within 48 h of incubation, approximately 4.36, 
11.54, 21.88 and 15.54 % of the cells underwent 
early apoptosis after treatment with 0 (no linalool 
treatment), 20, 40 and 80 µM of linalool 
respectively. Similarly, 6.07 %, 25.11 %, 29.34 % 
and 43.14 % of the cells underwent late 
apoptosis after treatment with 0 (no linalool 
treatment), 20, 40 and 80 µM of linalool 
respectively (Figure 4). 
 
Morphological characteristics of apoptosis  
 
Morphological study using inverted light 
microscopy revealed that linalool induced growth 
inhibition and apoptosis in DU145 prostate 
cancer cells. As shown in Figure 5A-D, the 
number of cells in the control and the ones 
treated with different concentrations of linalool 
increased from 0, 20, 40 and 80 µM dose. The 
cells with higher doses revealed that cellular 
shrinkage and blebbing occurred. This effect was 
shown to be related to linalool dose.  The 






Figure 4: Induction of apoptosis by linalool evaluated by Annexin V-FITC/PI dual staining. DU145 prostate 
cancer cells were treated with 20 μM (B), 40 μM (C) and 80 μM (D) of linalool for 48 h and analyzed using FACS 
Calibur flow cytometer as described in “Materials and Methods”. A, represents experiment control of untreated 
cells alone. Q1, Q2, Q3 and Q4 quadrants show percentage of normal healthy, early apoptotic, late apoptotic and 
necrotic cell populations respectively 
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Figure 5: Linalool inhibited the growth of DU145 prostate cancer cells as revealed by inverted light microscopy. 
Morphological changes of DU145 cells after treatment with linalool (magnification 400X). Cellular shrinkage was 
observed in linalool-treated cells (arrows). A represents control (untreated cells), B,C and D represent effect of 
20, 40 and 80 µM of linalool on cell morphology of DU145 cells.  The number of cells with shrinkage increase with 




Today, plant-based drugs continue to play an 
essential role in health care. It has been 
estimated by the World Health Organization that 
80 % of the population of the world rely mainly on 
traditional medicines for their primary health care 
[8]. Natural products have contributed 
significantly to the development of anticancer 
drugs. According to a recent review, among the 
79 FDA approved anticancer drugs and vaccines 
from 1983 - 2002, 9 were directly from the 
isolation of natural products and 21 were natural 
product derivatives [9]. 
 
Linalool has been reported to exhibit good 
inhibitory effects against breast, colorectal and 
liver cancer cells [10]. Cell cycle analysis also 
confirmed that linalool can lead to apoptosis. By 
using flow cytometry, it was reported that 
treatment with linalool significantly increased the 
sub-G1 phase and that there were more cells 
concentrated in the G1 phase. Linalool has also 
been reported to stimulate IFN-γ, IL-13, IL-2, IL-
21, IL-21R, IL-4, IL-6sR and TNF-α secretion 
[11,12]. Linalool has also been investigated for 
its ability to induce apoptosis and differentiation 
in human leukemia HL-60 cells [13,14]. Linalool 
reportedly possesses strong activity against 
U937 histiocytic lymphoma cells and P3HR1 
Burkitt lymphoma cells [13]. Moreover, several 
recent reports have revealed that linalool 
reverses doxorubicin resistance in human breast 
adenocarcinoma cells [15] and exhibits anti-
proliferative activity against certain solid tumor 
cells, such as melanoma and renal cell 
adenocarcinoma cells  and HepG2 [16]. 
Particularly, linalool induces apoptosis in human 
leukemia cells without affecting normal 
hematopoietic cell growth [17]. These terpenoid 
components become ligands in nuclear 
receptors, regulate expression of various genes 
and ameliorate conditions related to these 
diseases [18].  
 
In this study, linalool was found to exert 
anticancer effects against prostate cancer cells 
by inducing apoptosis and sub-G1 cell cycle 
phase arrest. Linalool even induced potent DNA 
fragmentation in these cells. It caused both early 
and late apoptosis with cell shrinkage and 
membrane blebbing which are characteristic 
features of apoptosis. 
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The findings of this work indicate that linalool 
exhibits potent dose-dependent as well as time-
dependent anticancer activity in human prostate 
cancer (DU145) cells by inducing apoptosis, 
DNA fragmentation and cell cycle arrest. these 
findings may pave way for future research on 
linalool in the hunt for novel and less toxic 
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